Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2020

Open Access 01-12-2020 | Ovarian Cancer | ASO Author Reflections

ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer

Authors: Karin Stålberg, MD, PhD, Björg Jónsdóttir, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

The peritoneal cancer index (PCI) was introduced by Paul Sugarbaker to describe peritoneal carcinomatosis, initially for colorectal cancer and mesothelioma.1 PCI illustrates the distribution and the volume of carcinomatosis. In colorectal cancer, PCI shows a linear relationship with overall survival2 and affects postoperative quality of life.3 It is not generally recommended to operate on patients with colorectal carcinomatosis with PCI over 20.4 Previous studies on PCI in ovarian cancer are few and heterogeneous, suggesting cutoffs for surgery from 10 to 25, and since many of the studies were conducted, surgery has become more extensive.5,6 …
Literature
1.
Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, editor. Peritoneal Carcinomatosis: Principles of Management. Boston, MA: Springer; 1996. p. 359–74.CrossRef
2.
Faron M, Macovei R, Goere D, Honore C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114–9.CrossRef
3.
Steffens D, Koh C, Ansari N, Solomon MJ, Brown K, McBride K, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: early results from a prospective cohort study of 115 patients. Ann Surg Oncol. 2020;27:1875–6.CrossRef
4.
Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res. 2017;9:259–66.CrossRef
5.
Llueca A, Serra A, Rivadulla I, Gomez L, Escrig J, MUAPOS Working Group. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16(1):37.CrossRef
6.
Lampe B, Kroll N, Piso P, Forner DM, Mallmann P. Prognostic significance of Sugarbaker’s peritoneal cancer index for the operability of ovarian carcinoma. Int J Gynecol Cancer. 2015;25(1):135–44.CrossRef
7.
Low RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2015;22(5):1708–15.CrossRef
8.
Metadata
Title
ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer
Authors
Karin Stålberg, MD, PhD
Björg Jónsdóttir, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08664-7

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue

ASO Author Reflections

ASO Author Reflections: Relationship of Cancer Diagnosis to Complications Following Pancreatoduodenectomy for Duodenal Adenoma: Extreme Force Versus the Right Weapon for the Right Problem

Head and Neck Oncology

Neck Dissection for Adenoid Cystic Carcinoma

Correction

Correction to: Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces

ASO Author Reflections

ASO Author Reflections: The De-Escalation of Sentinel Node Biopsy for Breast Cancer

ASO Author Reflections

ASO Author Reflections: Time for a Paradigm Shift in “Hormone Receptor Positive” Invasive Breast Cancer?

ASO Author Reflections

ASO Author Reflections: Robotic Oncologic Surgery